JP2024532403A5 - - Google Patents
Info
- Publication number
- JP2024532403A5 JP2024532403A5 JP2024513300A JP2024513300A JP2024532403A5 JP 2024532403 A5 JP2024532403 A5 JP 2024532403A5 JP 2024513300 A JP2024513300 A JP 2024513300A JP 2024513300 A JP2024513300 A JP 2024513300A JP 2024532403 A5 JP2024532403 A5 JP 2024532403A5
- Authority
- JP
- Japan
- Prior art keywords
- ttds
- group
- aib
- analog
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163236090P | 2021-08-23 | 2021-08-23 | |
| US63/236,090 | 2021-08-23 | ||
| US202263332994P | 2022-04-20 | 2022-04-20 | |
| US63/332,994 | 2022-04-20 | ||
| PCT/US2022/041095 WO2023028008A2 (en) | 2021-08-23 | 2022-08-22 | Combination of relaxin and vasopressin analogues for treatment of renal disorders or conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532403A JP2024532403A (ja) | 2024-09-05 |
| JP2024532403A5 true JP2024532403A5 (enExample) | 2025-08-29 |
Family
ID=85322130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513300A Pending JP2024532403A (ja) | 2021-08-23 | 2022-08-22 | 腎障害または状態の治療のためのリラキシン類似体とバソプレシン類似体との組み合わせ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240400638A1 (enExample) |
| EP (1) | EP4392440A4 (enExample) |
| JP (1) | JP2024532403A (enExample) |
| AU (1) | AU2022334113A1 (enExample) |
| CA (1) | CA3229783A1 (enExample) |
| MX (1) | MX2024002335A (enExample) |
| WO (1) | WO2023028008A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ766762A (en) * | 2018-01-31 | 2026-03-27 | Sanofi Sa | Modified lipidated relaxin b chain peptides and their therapeutic use |
| CN118510536A (zh) | 2021-11-11 | 2024-08-16 | 泰克托尼治疗股份有限公司 | 松弛素-2融合蛋白类似物及其使用方法 |
| AU2024270919A1 (en) | 2023-05-18 | 2026-01-15 | Tectonic Operating Company, Inc. | Relaxin-2 fusion protein analogs and methods of using same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015001488A (es) * | 2012-07-31 | 2015-04-08 | Novartis Ag | Tratamiento de la inflamacion utilizando serelaxina. |
| PE20191716A1 (es) * | 2017-02-08 | 2019-12-05 | Bristol Myers Squibb Co | Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos |
| NZ766762A (en) * | 2018-01-31 | 2026-03-27 | Sanofi Sa | Modified lipidated relaxin b chain peptides and their therapeutic use |
-
2022
- 2022-08-22 AU AU2022334113A patent/AU2022334113A1/en active Pending
- 2022-08-22 MX MX2024002335A patent/MX2024002335A/es unknown
- 2022-08-22 EP EP22861950.8A patent/EP4392440A4/en not_active Withdrawn
- 2022-08-22 WO PCT/US2022/041095 patent/WO2023028008A2/en not_active Ceased
- 2022-08-22 JP JP2024513300A patent/JP2024532403A/ja active Pending
- 2022-08-22 US US18/685,694 patent/US20240400638A1/en active Pending
- 2022-08-22 CA CA3229783A patent/CA3229783A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024532403A5 (enExample) | ||
| JP7541600B2 (ja) | Ｇｉｐアゴニスト化合物及び方法 | |
| JP7295871B2 (ja) | 修飾された脂質化リラキシンｂ鎖ペプチドおよびその治療的使用 | |
| US5932548A (en) | Lysine containing peptides for treatment of heart disease | |
| JP2021512099A5 (enExample) | ||
| US20240400638A1 (en) | Combination of relaxin and vasopressin analogues for treatment of renal disorders or conditions | |
| RU2016110153A (ru) | Новые пептиды и их аналоги для применения при лечении мукозита полости рта | |
| US6124263A (en) | Treatment of tumors by administration of growth hormone releasing compounds and their antagonists | |
| JP2026506334A (ja) | Ｎｍｕ受容体２アゴニスト | |
| CN1255426C (zh) | 用于治疗勃起功能障碍的肽 | |
| EP0842193B1 (en) | Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone | |
| ES2291372T3 (es) | Agonistas y antagonistas de urotensina-ii. | |
| Kutina et al. | Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats | |
| US10570174B2 (en) | Peptides for the treatment of malignant proliferative diseases | |
| US20210171604A1 (en) | Peptides for the treatment of type 2 diabetes | |
| WO2026068492A1 (en) | Compounds comprising modified w peptide | |
| CN118510796A (zh) | 用于治疗肾脏病症或疾患的松弛素和加压素类似物的组合 | |
| HK1083068A (en) | Lysine containing peptides for treatment of heart disease |